155 related articles for article (PubMed ID: 3499543)
41. In vitro induction of proteins by alpha-interferon in hairy cell leukemia.
Samuels BL; Golomb HM; Brownstein BH
Cancer Res; 1986 Aug; 46(8):4151-5. PubMed ID: 3731082
[TBL] [Abstract][Full Text] [Related]
42. Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies.
Steis RG; Smith JW; Urba WJ; Clark JW; Itri LM; Evans LM; Schoenberger C; Longo DL
N Engl J Med; 1988 Jun; 318(22):1409-13. PubMed ID: 3367950
[TBL] [Abstract][Full Text] [Related]
43. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity.
Chilosi M; Semenzato G; Cetto G; Ambrosetti A; Fiore-Donati L; Perona G; Berton G; Lestani M; Scarpa A; Agostini C
Blood; 1987 Nov; 70(5):1530-5. PubMed ID: 3117133
[TBL] [Abstract][Full Text] [Related]
44. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
[TBL] [Abstract][Full Text] [Related]
45. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
[TBL] [Abstract][Full Text] [Related]
46. The role of interferon in the treatment of hairy cell leukemia.
Ratain MJ; Vardiman JW; Golomb HM
Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
[TBL] [Abstract][Full Text] [Related]
47. Hairy cell leukemia associated with large granular lymphocyte leukemia: immunologic and genomic study, effect of interferon treatment.
Marolleau JP; Henni T; Gaulard P; Le Couedic JP; Gourdin MF; Divine M; Katz A; Tulliez M; Goossens M; Reyes F
Blood; 1988 Aug; 72(2):655-60. PubMed ID: 2840988
[TBL] [Abstract][Full Text] [Related]
48. The UCLA experience with type I interferons in hairy cell leukemia.
Glaspy JA; Jacobs AD; Golde DW
Leukemia; 1987 Apr; 1(4):323-6. PubMed ID: 3312839
[TBL] [Abstract][Full Text] [Related]
49. Is there a direct differentiation-inducing effect of human recombinant interferon on hairy cell leukemia in vitro?
Gressler VH; Weinkauff RE; Franklin WA; Golomb HM
Cancer; 1989 Jul; 64(2):374-8. PubMed ID: 2500232
[TBL] [Abstract][Full Text] [Related]
50. Hairy cell leukemia cells are relatively NK-insensitive targets.
Starling GC; Nimmo JC; Hart DN
Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
[TBL] [Abstract][Full Text] [Related]
51. Antibodies to interferon-alpha 2 in patients treated with interferon-alpha 2 for hairy cell leukemia.
Bekisz JB; zur Nedden DL; Enterline JC; Zoon KC
J Interferon Res; 1989 Sep; 9 Suppl 1():S1-7. PubMed ID: 2809275
[TBL] [Abstract][Full Text] [Related]
52. Discordant effect of interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia.
Lahat N; Aghai E; Kotler A; Kinarty A; Sobel E; Gruener N; Froom P
Blood; 1988 Apr; 71(4):1141-3. PubMed ID: 3258536
[TBL] [Abstract][Full Text] [Related]
53. A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomy.
Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
Leukemia; 1987 Apr; 1(4):337-40. PubMed ID: 3669759
[TBL] [Abstract][Full Text] [Related]
54. Immunosuppressive effects of recombinant interferon-alpha during long-term treatment of cancer patients.
Teichmann JV; Sieber G; Ludwig WD; Ruehl H
Cancer; 1989 May; 63(10):1990-3. PubMed ID: 2702571
[TBL] [Abstract][Full Text] [Related]
55. An interferon resistant variant of the hairy-cell leukemic cell line, Eskol: biochemical and immunological characterization.
Ozes ON; Klein SB; Reiter Z; Taylor MW
Leuk Res; 1993 Nov; 17(11):983-90. PubMed ID: 7694002
[TBL] [Abstract][Full Text] [Related]
56. Phenotypic changes on hairy cells exposed in vitro to interferons: a quantitative FACS study.
Till KJ; Cawley JC
Br J Haematol; 1989 Jul; 72(3):378-86. PubMed ID: 2504270
[TBL] [Abstract][Full Text] [Related]
57. Interferon-alpha-2C in the treatment of advanced hairy cell leukaemia. Results of a phase II trial.
Huber C; Flener R; Gastl G
Oncology; 1985; 42 Suppl 1():7-9. PubMed ID: 4080300
[TBL] [Abstract][Full Text] [Related]
58. Rearrangement of both immunoglobulin and T-cell receptor genes in a prolymphocytic variant of hairy cell leukemia patient resistant to interferon-alpha.
Giardina SL; Young HA; Faltynek CR; Jaffe ES; Clark JW; Steis RG; Urba WJ; Mathieson BJ; Gralnick H; Lawrence J
Blood; 1988 Nov; 72(5):1708-16. PubMed ID: 2846090
[TBL] [Abstract][Full Text] [Related]
59. Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
Urba WJ; Baseler MW; Kopp WC; Steis RG; Clark JW; Smith JW; Coggin DL; Longo DL
Blood; 1989 Jan; 73(1):38-46. PubMed ID: 2783373
[TBL] [Abstract][Full Text] [Related]
60. Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing.
Gastl G; Aulitzky W; Leiter E; Flener R; Huber C
Blut; 1986 May; 52(5):273-9. PubMed ID: 3635416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
